Expression of Smad7 in Cholangiocarcinoma: Prognostic Significance and Implications for Tumor Metastasis |
Huang, Qiang
(Department of General Surgery, the Affiliated Provincial Hospital of Anhui Medical University)
Liu, Lei (Department of General Surgery, the Affiliated Provincial Hospital of Anhui Medical University) Liu, Chen-Hai (Department of General Surgery, the Affiliated Provincial Hospital of Anhui Medical University) Shao, Feng (Department of General Surgery, the Affiliated Provincial Hospital of Anhui Medical University) Xie, Fang (Department of General Surgery, the Affiliated Provincial Hospital of Anhui Medical University) Zhang, Chuan-Hai (Department of General Surgery, the Affiliated Provincial Hospital of Anhui Medical University) Hu, San-Yuan (Department of General Surgery, Qilu Hospital of Shandong University) |
1 | Aljiffry M, Walsh M J, Molinari M (2009). Advance in diagnosis,treatment and palliation of cholangiocarcarcinoma: 1990-2009. World J Gastrointestinal, 15, 4240-62. DOI |
2 | Chen YK, Huang AH, Cheng PH, et a1(2012). Overexpression of Smad proteins, especially Smad7, in oral epithelial dysplasias. Clin Oral Investig, 6, 6. |
3 | Dahler AL, Cavanagh LL, Saunders NA (2001). Suppression of keratinocyte growth and differentiation by transforming growth factor beta1 involves multiple signaling pathways. J Invest Dermatol, 116, 266-74. DOI |
4 | Drabsch Y, Ten Dijke P (2012). TGF- signalling and its role in cancer progression and metastasis. Cancer Metastasis Rev, 7, 20. |
5 | Gratchev A, Kzhyshkowska J, Kannookadan S, et a1 (2008). Activation of a TGF-beta-specific multistep gene expression program in mature macrophages requires glucocorticoidmediated surface expression of TGF-beta receptor II. J Immunol, 180, 6553-65. DOI |
6 | Halder SK, Rachakonda G, Deane NG, et a1 (2008). Smad7 induces hepatic metastasis in colorectal cancer. Brit J Cancer, 4, 957-65. |
7 | Hayashi H, Abollah S, Qiu Y, et al (1997). The MAD-related protein Smad7 associates with the TGF-beta receptor and functions as an antagonist of TGF-beta signaling. Cell, 89, 1165-73. DOI |
8 | Iiizumi M, Liu W, Pai SK, et al (2008). Drug development against metastasis-related genes and their pathways: a rationale for cancer therapy. Biochim Biophys Acta, 1786, 87-104. |
9 | Iwatsuki M, Mimori K, Yokobori T, et al (2010). Epithelial-mesenchymal transition in cancer development and its clinical significance. Cancer Sci, 101, 293-9. DOI |
10 | Kalluri R, Weinberg RA(2009). The basics of epithelial-mesenchymal transition. J Clin Invest, 119, 1420-8. DOI |
11 | Kim YH, Lee HS, Lee HJ, et a1 (2004). Prognostic significance of the expression of Smad4 and Smad7 in human gastric carcinomas. Ann Oncol, 15, 574-80. DOI ScienceOn |
12 | Kleeff J, Ishiwata T, Maruyama H , et al(1999). The TGF-beta signaling inhibitor Smad7 enhances tumorigenicity in pancreatic cancer. Oncogene, 18, 5363-72. DOI ScienceOn |
13 | Kokkinos MA, wafai R, Wong MK, et al (2007). Vimentin and epithelial-mesenchymal transition in human breast cancer-observations in vitro and in vivo. Cells Tiss Organs, 185, 191-203. DOI |
14 | Lan HY, Chung AC (2011). Transforming growth factor- and Smads. Contrib Nephrol, 170, 75-82. DOI |
15 | Leng A, Liu T, He Y, Li Q, Zhang G (2009). Smad4/Smad7 balance: A role of tumorigenesis in gastric cancer. Exp Mol Pathol, 87, 48-53. DOI |
16 | Li H, Qin Y, Cui Y, et al (2011). Analysis of the surgical outcome and prognostic factors for hilar cholangiocarcinoma: a Chinese experience. Dig Surg, 28, 226-31. DOI |
17 | Li Y, Wang JP, Santen RJ, et al (2010). Estrogen stimulation of cell migration involves multiple signaling pathway interactions. Endocrinology, 151, 5146-56. DOI |
18 | Nakajima S, Doi R, Toyoda E, et al (2004). N-cadherin expression and epithelial-mesenchymal transition in pancreatic carcinoma. Clin Cancer Res, l0, 4125-33. |
19 | Liu Q, Zhang Y, Mao H, et a1 (2012). A crosstalk between the Smad and JNK signaling in the TGF--induced epithelialmesenchymal transition in rat peritoneal mesothelial cells. PLoS One, 7, e32009. DOI |
20 | Moustakas A, Heldin CH (2007). Signaling networks guiding epithelial-mesenchymal transitions during embryogenesis and cancer progression. Cancer Sci, 98, 1512-20. DOI ScienceOn |
21 | Neilson EG (2006). Mechanisms of disease: Fibroblasts-a new look at an old problem. Nat Clin Pract Nephrol, 2, 101-8. DOI |
22 | Park YN, Chae KJ, Oh B K, et al (2004). Expression of Smad7 in hepatocellular carcinoma and dysplastic nodules: resistance mechanism transforming growth factor-beta. Hepatogastroenterology, 51, 396-400. |
23 | Peinado H, Olmeda D, Cano A (2007). Snail, Zeb and bHLH factors in tumour progression: an alliance against the epithelial phenotype? Nat Rev Cancer, 7, 415-28. DOI |
24 | Pittman AM, Naranjo S, Webb E, et al(2009). The colorectal cancer risk at 18q21 is caused by a novel variant altering SMAD7 expression. Genome Res, 19, 987-93. DOI |
25 | Polette M, Mestdagt M, Bindels S, et al (2007). Beta-catenin and ZO-1: shuttle molecules involved in tumor invasionassociated epithelial-mesenchymal transition processes[J]. Cells Tiss Organs, 185, 61-5. DOI |
26 | Sabe H (2011). Cancer early dissemination: cancerous epithelial-mesenchymal transdifferentiation and transforming growth factor signalling. J Biochem, 149, 633-9. DOI |
27 | Zhu HJ, Iaria J, Sizeland AM(1999). Smad7 differentially regulates transforming growth factor beta-mediated signaling pathways. J Biol Chem, 274, 32258-64. DOI |
28 | Sandusky G, Berg DT, Richardson MA, et al (2002). Modulation of thrombomodulin-dependent activation of human protein C through differential expression of endothelial Smads[J]. J Biol Chem, 277, 49815-9. DOI |
29 | Sethi S, Sarkar FH, Ahmed Q, et al (2011). Molecular markers of epithelial-to-mesenchymal transition are associated with tumor aggressiveness in breast carcinoma. Transl Oncol, 4, 222-6. DOI |
30 | Yu H, Zhao G, Li H, et al (2012). Candesartan antagonizes pressure overload-evoked cardiac remodeling through Smad7 gene-dependent MMP-9 suppression. Gene, 1, 3. |
31 | Zhu L, Wang L, Wang X, et al (2011). Hepatic deletion of Smad7 in mouse leads to spontaneous liver dysfunction and aggravates alcoholic liver injury. PLoS One, 6, e17415. DOI |